The Essence of COVID-19 Diagnostics

SARS-CoV-2, a novel coronavirus that has not been previously identified in humans and the illness, coronavirus disease 2019 (COVID-19) was identified in Wuhan, China sparked a pandemic and caused havoc around the globe.

When there were no suitable diagnostic tests available during the early stages of the pandemic, clinicians were forced to treat COVID-19 patients solely on the basis of symptomatology. The diagnosis was greatly influenced by a person's residence, travels and close contact with someone who had an infection that was either proven or suspected.

SARS-CoV-2 was spreading by infected individuals who were asymptomatic, presymptomatic, and symptomatic, as well as by individuals who were ill but did not show any symptoms. (symptomatic). As a consequence, it was challenging to evaluate test performance and comprehend test results due to the wide range of transmission patterns.

A handful of SARS-CoV-2 infection diagnostic tests had been granted emergency use authorizations. (EUAs). It had been authorized to use these tests in a variety of settings by qualified professionals in order to raise diagnostic capacity and standards. Diagnostic tests, screening tests and surveillance tests made up the three main divisions of COVID-19 diagnostic testing.

Diagnostic tests included testing people with signs or symptoms of infection and people without symptoms who had a recent known or suspected COVID-19 exposure. Real-time Polymerase Chain Reaction (RT-PCR) emerged as the technique of choice for accurate detection.

Screening tests were conducted for individuals even if there is no reason to suspect the specific person has an infection or known COVID-19 exposure. The goal of screening tests was to find infected people before they showed symptoms or who might never show symptoms so that action might be taken to stop them from spreading the disease to others. Throughout the pandemic, rapid antigen tests were most frequently employed.

Surveillance tests were used for monitoring and characterization of the occurrence once detected. It was largely utilized to gather data for a population. These tests were used to track rising or falling infection rates or prevalence as well as to assess the impact of community actions like social distancing. As surveillance assays, next-generation sequencing and serological testing were employed.

In conclusion, the diagnostic laboratory should be able to determine the local infection rates and trends. The laboratory should follow the test methodology and adhere to all specifications in order to conduct testing, based on the facts and figures. The pandemic left its mark and brought to mind the catastrophe that can occur during such event. Being prepared for the future can be achieved through comprehending the concepts of various modalities.

COVID-19 Diagnostics

References:

1.Dinnes J, Deeks JJ, Adriano A, et al.; Cochrane COVID-19 Diagnostic Test Accuracy Group. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020(8):CD013705.
2.Hanson KE, Caliendo AM, Arias CA, et al. The Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing. Clin Infect Dis.2021.  
3.Hanson KE, Caliendo AM, Arias CA, et al. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing.2021.  
4.Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J. CRISPR Systems for COVID-19 Diagnosis. ACS Sens. 2021 Apr 23;6(4):1430-1445. 
5.Thorburn F.; Bennett S.; Modha S.; Murdoch D.; Gunson R.; Murcia P. R. The use of next generation sequencing in the diagnosis and typing of respiratory infections. J. Clin. Virol. 2015, 69, 96–100. 

Next Post Previous Post
No Comment
Add Comment
comment url